In conclusion, this study firstly links PITX2 loss-of-function mutation to ECD and ARS, which provides novel insight into the molecular mechanisms of CHD and ARS, implying potential implications in antenatal prophylaxis and personalized treatment of CHD and ARS. This evidence concerns the gene PITX2 and coronary artery disorder.